Stifel Reiterates Hold on ALX Oncology Holdings, Lowers Price Target to $3
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Bradley Canino has reiterated a Hold rating on ALX Oncology Holdings (NASDAQ:ALXO) and lowered the price target from $5 to $3.
August 09, 2024 | 12:25 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Stifel analyst Bradley Canino has reiterated a Hold rating on ALX Oncology Holdings and lowered the price target from $5 to $3.
The lowered price target from $5 to $3 indicates a negative outlook on ALX Oncology Holdings' future performance, which is likely to put downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100